The influence of genomics and proteomics on the development of potential vaccines against meningococcal infection

Genome Medicine

Volumn 2, Issue 7, 2010, Pages

  Heckels, John E ^a,b   Williams, Jeannette N ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN;

BACTERIAL GENOME; GENOMICS; HUMAN; INFECTION PREVENTION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEOMICS; REVIEW; VACCINATION;

EID: 77957938048     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm164     Document Type: Review

References (30)

1. Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001, 357:195-196. 10.1016/S0140-6736(00)03594-7, 11213098.
2. Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 1983, 2:355-357. 10.1016/S0140-6736(83)90340-9, 6135869.
3. Bjune G, Hoiby EA, Gronnesby JK, Arnesen O, Holstfredriksen J, Halstensen A, Holten E, Lindbak AK, Nokleby H, Rosenqvist E, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991, 338:1093-1096. 10.1016/0140-6736(91)91961-S, 1682541.
4. Oster P, Lennon D, O'Hallahan J, Mulholland K, Reid S, Martin D. MeNZB (TM): a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 2005, 23:2191-2196. 10.1016/j.vaccine.2005.01.063, 15755593.
5. Sierra GVG, Campa HC, Varcacel NM, Garcia IL, Izquierdo PL, Sotolongo PF, Casanueva GV, Rico CO, Rodriguez CR, Terry MH. Vaccine against group B Neisseria meningitidis: Protection trial and mass vaccination results in Cuba. NIPH Annals 1991, 14:195-210.
6. Boslego J, Garcia J, Cruz C, Zollinger W, Brandt B, Ruiz S, Martinez M, Arthur J, Underwood P, Silva W, et al. Efficacy, safety, and immunogenicity of a meningococcal group B (15 P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine 1995, 13:821-829. 10.1016/0264-410X(94)00037-N, 7483804.
7. Milagres LG, Ramos SR, Sacchi CT, Melles CEA, Vieira VSD, Sato H, Brito GS, Moraes JC, Frasch CE. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun 1994, 62:4419-4424. 303125, 7927704.
8. Wedege E, Hoiby EA, Rosenqvist E, Bjune G. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 1998, 66:3223-3231. 108336, 9632589.
9. Frasch CE, van Alphen L, Holst J, Poolman JT, Rosenqvist E. Outer membrane protein vesicle vaccines for meningococcal disease. Meningococcal Vaccines 2001, 81-107. Totowa, New Jersey: Humana Press, Pollard AJ, Maiden MCJ.
10. Milagres LG, Gorla MC, Sacchi CT, Rodrigues MA. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunisation with an outer membrane vaccine. Infect Immun 1998, 66:4755-4761. 108586, 9746575.
11. Rouppe van der VE, van Dijken H, Kuipers B, van der Biezen J, van der Ley P, Meylis J, Claassen I, Poolman J. Human B- and T-cell responses after immunisation with a hexavalent PorA meningocccal outer membrane vesicle vaccine. Infect Immun 1997, 65:5184-5190. 175747, 9393814.
12. Jordens JZ, Williams JN, Jones GR, Christodoulides M, Heckels JE. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students. Infect Immun 2004, 72:6503-6510. 10.1128/IAI.72.11.6503-6510.2004, 523012, 15501781.
13. Parkhill J, Achtman M, James KD, Bentley SD, Churcher C, Klee SR, Morelli G, Basham D, Brown D, Chillingworth T, Davies RM, Davis P, Devlin K, Feltwell T, Hamlin N, Holroyd S, Jagels K, Leather S, Moule S, Mungall K, Quail MA, Rajandream MA, Rutherford KM, Simmonds M, Skelton J, Whitehead S, Spratt BG, Barrell BG. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 2000, 404:502-506. 10.1038/35006655, 10761919.
14. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, Ketchum KA, Hood DW, Peden JF, Dodson RJ, Nelson WC, Gwinn ML, DeBoy R, Peterson JD, Hickey EK, Haft DH, Salzberg SL, White O, Fleischmann RD, Dougherty BA, Mason T, Ciecko A, Parksey DS, Blair E, Cittone H, Clark EB, Cotton MD, Utterback TR, Khouri H, Qin H, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 2000, 287:1809-1815. 10.1126/science.287.5459.1809, 10710307.
15. Bentley SD, Vernikos GS, Snyder LA, Churcher C, Arrowsmith C, Chillingworth T, Cronin A, Davis PH, Holroyd NE, Jagels K, Maddison M, Moule S, Rabbinowitsch E, Sharp S, Unwin L, Whitehead S, Quail MA, Achtman M, Barrell B, Saunders NJ, Parkhill J. Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet 2007, 3:e23. 10.1371/journal.pgen.0030023, 1797815,1797815, 17305430.
16. Pizza M, Scarlato V, Masignani V, Giuliani MM, Aricò B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820. 10.1126/science.287.5459.1816, 10710308.
17. Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 2006, 103:10834-10839. 10.1073/pnas.0603940103, 2047628, 16825336.
18. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Borrow R. Characterisation of fHbp, nhba (gna2132), nadA, porA and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008, and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol 2010, 17:919-929. 10.1128/CVI.00027-10, 2884420, 20375242.
19. Pajon R, Yero D, Niebla O, Climent Y, Sardinas G, Garcia D, Perera Y, Llanes A, Delgado M, Cobas K, Caballero E, Taylor S, Brookes C, Gorringe A. Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes. Vaccine 2009, 28:532-541. 10.1016/j.vaccine.2009.09.128, 19837092.
20. Tsai CM, Frasch CE, Mocca LF. Five structural classes of major outer-membrane proteins in Neisseria meningitidis. J Bacteriol 1981, 146:69-78. 217053, 6783622.
21. Derrick JP, Heckels JE, Virji M. Major outer membrane proteins of meningococci. Meningococcal disease: Infection Biology, Vaccination, Clinical Management 2006, 181-200. Weinheim: Wiley-VCH, Frosch M, Maiden MC.
22. Vipond C, Wheeler JX, Jones C, Feavers IM, Suker J. Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry. Hum Vaccin 2005, 1:80-84. 10.4161/hv.1.2.1651, 17038831.
23. Vipond C, Suker J, Jones C, Tang C, Feavers IM, Wheeler JX. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics 2006, 6:3400-3413. 10.1002/pmic.200690086, 16645985.
24. Vaughan TE, Skipp PJ, O'Connor CD, Hudson MJ, Vipond R, Elmore MJ, Gorringe AR. Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine 2006, 24:5277-5293. 10.1016/j.vaccine.2006.03.013, 16682101.
25. Williams JN, Skipp PJ, Humphries HE, Christodoulides M, O'Connor CD, Heckels JE. Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide deficient mutant. Infect Immun 2007, 75:1364-1372. 10.1128/IAI.01424-06, 1828559, 17158897.
26. Gardy JL, Laird MR, Chen F, Rey S, Walsh CJ, Ester M, Brinkman FS. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2004, 21:617-623. 10.1093/bioinformatics/bti057, 15501914.
27. Mendum TA, Newcombe J, McNeilly CL, Mcfadden J. Towards the immunoproteome of Neisseria meningitidis. PLoS ONE 2009, 4:e5940. 10.1371/journal.pone.0005940, 2691954, 19529772.
28. Williams JN, Skipp PJ, O'Connor CD, Christodoulides M, Heckels JE. Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates. Infect Immun 2009, 77:5080-5089. 10.1128/IAI.00701-09, 2772525, 19737898.
29. Wright JC, Williams JN, Christodoulides M, Heckels JE. Immunisation with recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis. Infect Immun 2002, 70:4028-4034. 10.1128/IAI.70.8.4028-4034.2002, 128133, 12117908.
30. Humphries HE, Williams JN, Blackstone R, Jolley KA, Yuen HM, Christodoulides M, Heckels JE. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis. Vaccine 2006, 24:36-44. 10.1016/j.vaccine.2005.07.056, 16105711.